POS1541-HPR PAIN CATASTROPHIZING IS FREQUENT AND IMPACTS THE LIFE AND FUNCTION OF PATIENTS WITH SPONDYLOARTHRITIS

Abstract

BackgroundPsychological care for patients with spondyloarthritis (SpA) should be standard practice if we aim to achieve better outcomes. In fact, pain catastrophizing, anxiety, and depression are to look for when the patient remains unsatisfied despite the clinicobiological control of the disease.ObjectivesTo assess the presence of pain catastrophizing among patients with SpA.MethodsWe conducted a cross-sectional study including patients with SpA, fulfilling the Assessment of SpondyloArthritis International Society (ASAS) 2009 criteria. For all patients, we collected the socio-demographic data and disease characteristics, the following scores: the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath ankylosing spondylitis functional index (BASFI), the Ankylosing spondylitis quality of life score (ASQOL) were used to evaluate respectively disease activity, functional status and quality of life. The presence of pain catastrophizing was assessed by the arabic validated version of Pain catastrophizing score (PCS) and nociplastic pain by Central Sensitization Inventory (CSI).ResultsWe included 60 SpA patients (sex ratio=1,72). Mean age was 39,4 years ± 11,08. Mean disease duration was 11,37 years ±7,23. Mean BASDAI score was 3,53± 3,34, mean BASFI was 4,01 ±2,53 and mean ASQOL score was 6,3 ±5,12. Mean PCS was 15,73 ± 13,893. thirteen patients (21,7%) had PCS >30 which indicates clinically relevant level of catastrophizing. PCS was significantly higher in men (mean PCS was 19,29 in men versus 9,59 in females), p=0,003. Clinically relevant level of catastrophizing (PCS>30) was significantly associated with age: mean age was 45,61 years in patients with PCS>30 compared to 37,47 in patients with lower PCS (p=0,022). Higher PCS was correlated with greater central sensitization assessed by the CSI (p<0,0001, r=0,621), poorer quality of life assessed by the ASQOL (p<0,0001, r=0,818) and greater functional impairment appraised by BASFI (p=0,009, r=0,347). No correlation was shown between PCS and age (p=0,640, r=0,062), age at disease onset (p=0,580, r=-0,84), disease duration (p=0,805, r=0,037), patient’s global assessment (p=0,211, r=0,197), CRP value (p= 0,425, r=-0,130) and BASDAI score (p=0,073, r=0,244).ConclusionPain catastrophizing was not influenced by inflammation parameters. PCS was correlated with greater central sensitization, poorer quality of life and greater functional impairment. Therefore, psycho-education should be investigated among patients with SpA.Disclosure of InterestsNone declared